Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Finding what is not there: unwarranted claims of an effect of psychosocial intervention on recurrence and survival.

Stefanek ME, Palmer SC, Thombs BD, Coyne JC.

Cancer. 2009 Dec 15;115(24):5612-6. doi: 10.1002/cncr.24671.

2.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
3.

Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B.

Tross S, Herndon J 2nd, Korzun A, Kornblith AB, Cella DF, Holland JF, Raich P, Johnson A, Kiang DT, Perloff M, Norton L, Wood W, Holland JC.

J Natl Cancer Inst. 1996 May 15;88(10):661-7.

4.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

5.

Hormonal therapies for early breast cancer: systematic review and economic evaluation.

Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L.

Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. Review.

7.

Attitudes of Canadian oncology practitioners toward psychosocial interventions in clinical and research settings in women with breast cancer.

Del Giudice ME, Leszcz M, Pritchard KI, Vincent L, Goodwin P.

Psychooncology. 1997 Sep;6(3):178-89.

PMID:
9313283
8.

Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence.

Gotay CC, Moinpour CM, Unger JM, Jiang CS, Coleman D, Martino S, Parker BJ, Bearden JD, Dakhil S, Gross HM, Lippman S, Albain KS.

J Clin Oncol. 2007 May 20;25(15):2093-9.

9.
10.

Support groups in advanced breast cancer.

Goodwin PJ.

Cancer. 2005 Dec 1;104(11 Suppl):2596-601. Review.

11.

Impact of psychotherapy on cancer survival: time to move on?

Boesen EH, Johansen C.

Curr Opin Oncol. 2008 Jul;20(4):372-7. doi: 10.1097/CCO.0b013e3283021690. Review.

PMID:
18525330
12.
13.

Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial.

Spiegel D, Butler LD, Giese-Davis J, Koopman C, Miller E, DiMiceli S, Classen CC, Fobair P, Carlson RW, Kraemer HC.

Cancer. 2007 Sep 1;110(5):1130-8.

14.

Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group.

Liljegren G, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J.

J Natl Cancer Inst. 1994 May 4;86(9):717-22.

PMID:
8158702
15.

Nonsomatic treatment of depression.

Sherrill JT, Kovacs M.

Child Adolesc Psychiatr Clin N Am. 2002 Jul;11(3):579-93. Review.

PMID:
12222084
16.

Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial.

Kissane DW, Grabsch B, Clarke DM, Smith GC, Love AW, Bloch S, Snyder RD, Li Y.

Psychooncology. 2007 Apr;16(4):277-86.

PMID:
17385190
17.

Psychosocial interventions in breast cancer: to light a candle.

Kaufmann PG.

Cancer. 2009 Dec 15;115(24):5617-9. doi: 10.1002/cncr.24659. No abstract available.

19.

Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial.

Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-Davis J, Fobair P, Carlson RW, Kraemer HC, Spiegel D.

Arch Gen Psychiatry. 2001 May;58(5):494-501.

PMID:
11343530
20.

[Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].

Fodor J, Polgár C, Németh G.

Orv Hetil. 2000 Jul 9;141(28):1551-5. Review. Hungarian.

PMID:
10957865
Items per page

Supplemental Content

Write to the Help Desk